< Back to latest news & events

Knowledge Hub

The Unitary Patent gets more unified

October 2015

Italy has joined the Unitary Patent as the 26th member of the enhanced cooperation on Unitary Patent protection. This is a boost for the Unitary Patent, as Italy is the fourth biggest market in Europe in terms of patent validation.

So far 8 Member States have ratified the agreement on the Unified Patent Court which will eventually bring the Unitary Patent into effect: Austria, France, Belgium, Sweden, Denmark, Malta, Luxembourg and Portugal. The European Commission has urged all remaining participating EU countries to ratify the UPC Agreement as soon as possible so that the Unitary Patent package comes into force by the end of 2016 (13 countries, including France, Germany and the UK must ratify to bring the agreement into effect).

Other measures to help bring the Unitary Patent into force have also been agreed. On October 1st 2015, a protocol to the UPC Agreement was signed by representatives of the member states. The protocol will allow some parts of the UPC agreement to be applied early. This includes final decisions on the practical set up of the Court, for example, the recruitment of judges and testing of IT systems. The provisional application phase will also be used to allow for early registration of opt-out demands.

This latest step towards bringing the Unified Patent Court into operation shows the commitment of the parties to meet the ambitious timescale of the UPC opening at the start of 2017. But will patentees be ready?

Latest updates

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article